Global Stirred tank Single use Bioreactors Market Size By Type (1L-10L, 11L-100L), By Application (Research and Development (RAndD), Process Development), By Region, And Segment Forecasts, 2023 to 203...

The Global Stirred Tank Single-Use Bioreactors Market was valued at USD 1.1 billion in 2023 and is projected to surpass USD 3.2 billion by 2031, growing at a CAGR of 14.2% during the forecast period of 2023–2031. The growth is fueled by increasing biopharmaceutical production, rising demand for flexible and scalable bioprocessing technologies, and cost-efficiency in upstream bioproduction. Single-use stirred tank bioreactors are gaining prominence due to their operational advantages such as reduced risk of cross-contamination, faster batch turnaround times, and lower capital and cleaning costs. These systems are vital for research institutions, contract manufacturing organizations (CMOs), and biopharma companies focused on vaccines, cell therapies, and monoclonal antibodies.

Drivers

1. Increasing Demand for Biopharmaceuticals:

The global rise in chronic and infectious diseases is accelerating demand for biologics, vaccines, and personalized medicines. Stirred tank single-use bioreactors are critical in scaling up bioproduction while maintaining consistency and sterility.

2. Flexibility and Operational Efficiency:

These bioreactors offer plug-and-play functionality with reduced setup and validation time, which makes them ideal for multiproduct manufacturing facilities. Their ease of use is enhancing adoption across both clinical and commercial production.

3. Cost-Effectiveness and Contamination Risk Mitigation:

Compared to stainless steel systems, single-use bioreactors eliminate the need for cleaning and sterilization, significantly reducing water and energy usage, and ensuring a sterile environment, thus minimizing batch failures.

Restraints

1. Limitations in Large-Scale Production:

Although widely adopted in R&D and clinical-scale operations, scalability to large-volume commercial manufacturing remains a challenge for some stirred tank single-use systems.

2. Waste Management Concerns:

The single-use nature leads to higher plastic waste generation, raising sustainability concerns and regulatory scrutiny regarding the disposal of biohazardous materials.

Opportunity

1. Expansion of Cell and Gene Therapy Manufacturing:

The increasing number of clinical trials and product approvals in the cell and gene therapy space is driving demand for single-use systems that offer sterility, flexibility, and small-batch processing capabilities.

2. Technological Advancements in Bioreactor Design:

Innovations such as enhanced mixing efficiency, integrated sensors, and advanced control systems are improving the performance of stirred tank single-use bioreactors, expanding their suitability for complex biologics manufacturing.

Market by System Type Insights

The Sub-200L bioreactors segment held the largest market share in 2023 due to its widespread use in early-phase drug development and small-batch production. However, the 200L–1000L segment is expected to witness the fastest growth, fueled by increasing mid- to large-scale production requirements in monoclonal antibody and vaccine manufacturing.

Market by End-use Insights

In 2023, Biopharmaceutical Companies dominated the market, accounting for over 50% of the global revenue. These organizations are increasingly transitioning to single-use platforms for faster production cycles and cost savings. Meanwhile, Contract Manufacturing Organizations (CMOs) are anticipated to be the fastest-growing segment, driven by outsourcing trends and the need for flexible manufacturing solutions.

Market by Regional Insights

North America led the market in 2023, backed by strong biopharmaceutical infrastructure, robust R&D investments, and rapid adoption of novel manufacturing technologies. Asia-Pacific is projected to exhibit the highest CAGR during the forecast period, with countries like China, India, and South Korea heavily investing in bioproduction capabilities and regulatory improvements.

Competitive Scenario

Key players in the global stirred tank single-use bioreactors market include:

Sartorius AG

Thermo Fisher Scientific Inc.

Danaher Corporation (Cytiva)

Merck KGaA

Eppendorf AG

PBS Biotech Inc.

ABEC Inc.

Applikon Biotechnology (Getinge)

Solaris Biotech

Pierre Guérin Technologies

These companies are engaged in capacity expansions, partnerships with biotech firms, and product innovation. For instance:

In 2024, Sartorius AG introduced an advanced single-use bioreactor platform with enhanced mixing capabilities for vaccine development.

Thermo Fisher launched a modular stirred tank system tailored for gene therapy applications in 2023.

In 2025, Danaher’s Cytiva business expanded its manufacturing site in the U.S. to boost supply of single-use components.

Scope of Work – Global Stirred Tank Single-Use Bioreactors Market

Report Metric Details

Market Size (2023) USD 1.1 billion

Projected Market Size (2031) USD 3.2 billion

CAGR (2023–2031) 14.2%

Market Segments By System Type, By End-use, By Region

Growth Drivers Rising biologics demand, cost efficiency, flexibility

Opportunities Cell & gene therapy, technological innovations

Key Market Developments

2023: Thermo Fisher Scientific introduced a new line of hybrid bioreactors integrating single-use and reusable components to meet diverse customer needs.

2024: Sartorius AG partnered with a leading biotech firm to develop specialized stirred tank bioreactors for CAR-T cell manufacturing.

2025: Merck KGaA announced the expansion of its M Lab Collaboration Centers to support scale-up of single-use bioreactor technologies.

FAQs

1) What is the current market size of the Global Stirred Tank Single-Use Bioreactors Market?

The market was valued at USD 1.1 billion in 2023.

2) What is the major growth driver of the Global Stirred Tank Single-Use Bioreactors Market?

The key driver is the increasing demand for flexible and efficient biomanufacturing solutions, particularly in the biopharmaceutical industry.

3) Which is the largest region during the forecast period in the Global Stirred Tank Single-Use Bioreactors Market?

North America holds the largest market share due to its advanced biotech ecosystem and high adoption rate of single-use technologies.

4) Which segment accounted for the largest market share in the Global Stirred Tank Single-Use Bioreactors Market?

The Sub-200L system type segment accounted for the largest share in 2023.

5) Who are the key market players in the Global Stirred Tank Single-Use Bioreactors Market?

Key players include Sartorius AG, Thermo Fisher Scientific, Danaher (Cytiva), Merck KGaA, and Eppendorf AG.